BioTrack Capital
Overview
BioTrack Capital is a healthcare-focused investment firm that specializes in investing in and incubating innovative medical and health startups in China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adai Technology (Beijing) Co., Ltd. | Aug 2021 | Series A Extension | Lead |
| MedMind Technology Co., Ltd. | Jun 2021 | Series C | Lead |
| Beijing Clickalign Medical Equipment Co., Ltd. | Oct 2020 | Series A Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioTrack Capital based?
BioTrack Capital is headquartered in Shanghai, China.
When was BioTrack Capital founded?
BioTrack Capital was founded in 2017.
How many portfolio companies does BioTrack Capital have?
BioTrack Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in BioTrack Capital's portfolio?
Recent investments visible on Caplight include Adai Technology (Beijing) Co., Ltd., MedMind Technology Co., Ltd., Beijing Clickalign Medical Equipment Co., Ltd..
What was BioTrack Capital's most recent investment?
BioTrack Capital's most recent investment on Caplight was in Adai Technology (Beijing) Co., Ltd. in 2021.
What sectors does BioTrack Capital focus on?
BioTrack Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Real Estate & PropTech, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does BioTrack Capital focus on?
BioTrack Capital typically invests at the Early stage.
What is BioTrack Capital's AUM?
BioTrack Capital's assets under management are estimated at over $1.4B.